August 3, 2021 Liq. Handling & Robotics

Pacific Biosciences Acquires Circulomics – A Leading High Molecular Weight DNA Extraction Company

MENLO PARK, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB) (“Pacific Biosciences” or “PacBio”), a leading provider of high-quality, long-read sequencing platforms, announced today that it acquired Circulomics Inc. (“Circulomics”), a Maryland-based biotechnology company focused on delivering highly differentiated sample prep products that enable genomic workflows. Scientists recognize Circulomics... Read more

August 3, 2021 PAI Top-10 PR/Corporate

Xylem Reports Second Quarter 2021 Results

29% organic orders growth on broad underlying demand across segments Revenue growth 16% on a reported basis, 11% organically Adjusted EBITDA margin of 17.3%, up 200 basis points; net income as a percentage of revenue of 8.4%, up 570 basis points Reported net income of $113 million or $0.62 per share; adjusted net income of... Read more

August 3, 2021 Acad, Gov/Utilities

US FDA grants Priority Review to Roche’s Tecentriq as adjuvant treatment for certain people with early non-small cell lung cancer

Basel, 3 August 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application (sBLA) and granted Priority Review for Tecentriq® (atezolizumab) as adjuvant treatment following surgery and platinum-based chemotherapy for people with non-small cell lung cancer (NSCLC) whose tumours... Read more

August 2, 2021 Life Science Tools M&A, Partnerships

Rigaku Acquires Life Science Imaging Equipment Manufacturer MILabs

Full-Scale Entry into the Global Life Sciences Business Rigaku Corporation (Headquarters: Akishima-shi, Tokyo; President: Toshiyuki Ikeda; “Rigaku”), a leading manufacturer of X-ray analysis equipment, has acquired all issued shares of MILabs B.V. (Headquarters: Houten, The Netherlands; CEO and CSO: Dr. Frederik Beekman; “MILabs”) on August 2, 2021, as part of their full-scale effort to enter... Read more

August 2, 2021 Lab Top-10 PAI Top-10 PR/Corporate

Bruker Reports Second Quarter 2021 Financial Results

Q2 2021 revenue growth of 34.4% year-over-year; organic revenue growth of 27.2% Q2 2021 GAAP EPS of $0.38; non-GAAP EPS of $0.44, compared to $0.21 in Q2 2020 Strong financial performance in the Bruker Scientific Instruments and BEST businesses drives a further increase in fiscal year 2021 guidance BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR)... Read more